Dupilumab improves hand, foot atopic dermatitis in phase 3 study

10 days ago - By Healio

NEW ORLEANS - Patients with hand and foot atopic dermatitis experienced significant improvement with dupilumab, which sustained an acceptable safety profile, according to phase 3 study results presented here.
“These results are the first to highlight how Dupixent can improve signs and symptoms of atopic hand and foot dermatitis, which is very difficult to treat,” Eric Simpson, MD, MCR, Frances J. Storrs Medical Dermatology Professor at Oregon Health & Science University, told Healio concerning his presentation at the American Academy of Dermatology Annual Meeting. “In
Read more ...

  Tweet

Delgocitinib safe, efficacious in chronic hand eczema

10 days ago - By Healio

NEW ORLEANS - Phase 3 trial results found delgocitinib cream to significantly improve patient and clinician-reported outcomes of hand eczema, according to a presenter at the American Academy of Dermatology Annual Meeting.
“Chronic hand eczema is one of the most frequent and chronic inflammatory disorders affecting hands,” Robert Bissonnette, MD, MSc, CEO and medical director of Innovaderm, said during his presentation.
Current chronic hand eczema treatments often have unsatisfactory results, Bissonnette continued.
The phase 3 DELTA 1 trial included 487 adult patients with
Read more ...

  Tweet

Search by Tags

Dermatology Hands Eczema